| |
Centre for Policy on Ageing | |
 | |
|
| Antipsychotic prescribing to older people living in care homes and the community in England and Wales | | Author(s) | S M Shah, I M Carey, T Harris |
| Journal title | International Journal of Geriatric Psychiatry, vol 26, no 4, April 2011 |
| Pages | pp 423-434 |
| Source | http://www.interscience.wiley.com/journal/gps |
| Keywords | Mental disorder ; Drugs ; Care homes ; Residents [care homes] ; Community care ; England ; Wales. |
| Annotation | This paper describes and compares antipsychotic prescribing to older people in care homes and the community in England and Wales. 3,677 (0.9%) patients in the community and 2,173 (20.9%) in care homes (20.5% in residential homes, 21.7% in nursing homes) received an antipsychotic medication prescription in the 90 days preceding the study. Most patients had received prescriptions for more than three months and 60% of prescriptions were for atypical antipsychotics. In patients without severe mental illness, 2,367 (0.6%) patients in the community and 1,765 (18.2%) in care homes received antipsychotic medication; such prescribing was common for patients with recorded dementia (30.2% in care homes, 10.1% in the community). In care homes, younger age and living in the North of England predicted prescribing, but care home type did not. In the community, female gender, increasing age, living in a deprived area and the North predicted prescribing. Study findings show that despite safety concerns, antipsychotic prescribing is markedly higher in care homes than in the community, and strongly associated with dementia in both settings. In England and Wales, it is estimated that 54,000 older care home patients and 50,000 community patients received antipsychotic medication without a diagnosis of severe mental illness. (JL). |
| Accession Number | CPA-110815017 A |
| Classmark | E: LLD: KW: KX: PA: 82: 9 |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|